13F Pro

Hedge Funds Similar to Pivotal bioVenture Partners Investment Advisor

13F Portfolio OverlapQ1 2026Pivotal bioVenture Partners Investment Advisor portfolio →
Institutional-grade research for retail investors

Most similar hedge funds by 13F overlap

Pivotal bioVenture Partners Investment Advisor LLC is an institutional investor managing $280M across 13 U.S. equity positions as of Q1 2026. Based on the overlap of conviction holdings in their latest 13F filings, the hedge funds with portfolios most similar to Pivotal bioVenture Partners Investment Advisor are Nan Fung Group Ltd, Velan Investment, NEXTBio, with shared positions in $EVMN, $OCS, $MPLT, $RXRX, $BOLT, $AVTX. The full ranking of 11 similar funds is below.

#1Nan Fung Group Holdings LtdSmart money
Substantial overlap · 5 shared positions
$EVMN$OCS$MPLT$RXRX$BOLT
$121M
24 positions
#2Velan Capital Investment Management LPActive
Notable overlap · 4 shared positions
$EVMN$MPLT$AVTX$IMNM
$160M
49 positions
#3NEXTBio Capital Management LPActive
Notable overlap · 4 shared positions
$ZBIO$PCVX$EVMN$OCS
$215M
24 positions
#4SUPERSTRING CAPITAL MANAGEMENT LPActive
Notable overlap · 3 shared positions
$PCVX$MPLT$TRVI
$140M
35 positions
#5SILVERARC CAPITAL MANAGEMENT, LLCActive
Notable overlap · 4 shared positions
$IMNM$ZBIO$PCVX$TRVI
$980M
73 positions
#6MPM BioImpact LLCActive
Some overlap · 3 shared positions
$TRVI$EVMN$ARQT
$1.3B
41 positions
#7Octagon Capital Advisors LPActive
Some overlap · 3 shared positions
$BIOA$TRVI$EVMN
$904M
29 positions
#8GREAT POINT PARTNERS LLCActive
Some overlap · 3 shared positions
$ZBIO$EVMN$AVTX
$435M
42 positions
#9Propel Bio Management, LLCActive
Some overlap · 3 shared positions
$OCS$TRVI$EVMN
$159M
38 positions
#10NAN FUNG TRINITY (HK) LtdPassive
Some overlap · 3 shared positions
$IMNM$TRVI$PCVX
$911M
62 positions
#11StemPoint Capital LPActive
Some overlap · 3 shared positions
$ARQT$BIOA$EVMN
$515M
82 positions

Compare Pivotal bioVenture Partners Investment Advisor’s portfolio side by side

See the exact shared positions, conviction overlap, sector alignment, and where these funds diverge — and run the same analysis on any of 8,700+ institutions.

View Pivotal bioVenture Partners Investment Advisor’s holdings

Similarity is derived from each fund’s latest 13F-HR filing with the SEC. Funds are ranked by the overlap of distinctive conviction holdings; near-universal mega-cap positions are excluded so the ranking reflects shared strategy, not common index exposure. Data is informational only and not investment advice.